Français
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
9 résultats
Treatment of acute pulmonary edema with arginine esters
Seuls les utilisateurs enregistrés peuvent traduire des articles
Se connecter S'inscrire
The present invention relates to novel therapeutic composition, particularly useful against acute pulmonary edema, shock caused by bacterial endotoxins, hyperfibrinolysis and anaphylactic shock. More specifically, the present invention relates to esters of L-arginine.
Many esters of L-arginine are
1, 2, 4-triazolone derivative and use thereof as an antagonist on the arginine-vasopressin 1B receptor
Seuls les utilisateurs enregistrés peuvent traduire des articles
Se connecter S'inscrire
CROSS REFERENCE TO RELATED APPLICATIONS
This application is a National Stage of International Application No. PCT/JP2011/072556, filed on Sep. 30, 2011, which claims priority from Japanese Patent Application Nos. 2010-224233, filed Oct. 1, 2010 and JP 2011-054500, filed Mar. 11, 2011, the contents
Reaction product of arginine and p-aminobenzoic acid, cosmetic, and human and animal health compositions thereof
Seuls les utilisateurs enregistrés peuvent traduire des articles
Se connecter S'inscrire
BACKGROUND OF THE INVENTION
1. Field of the Invention
This invention relates to cosmetic and human and animal health compositions, and, more particularly, to the reaction product of arginine and p-aminobenzoic acid (PABA), and compositions thereof, useful for treating wounds, lesions, burns,
Reaction product of arginine and p-aminobenzoic acid, cosmetic, and human and animal health compositions thereof
Seuls les utilisateurs enregistrés peuvent traduire des articles
Se connecter S'inscrire
BACKGROUND OF THE INVENTION
1. Field of the Invention
This invention relates to cosmetic and human and animal health compositions, and, more particularly, to the reaction product of arginine and p-aminobenzoic acid (PABA), and compositions thereof, useful for treating wounds, lesions, burns,
Treatment of shock
Seuls les utilisateurs enregistrés peuvent traduire des articles
Se connecter S'inscrire
The present invention relates to novel therapeutic composition, particularly useful against acute pulmonary edema, shock caused by bacterial endotoxins, hyperfibrinolysis and anaphylactic shock. More specifically, the present invention relates to esters of L-arginine.
Many esters of L-arginine are
1,3-dihydro-2H-indole-2-one compound and pyrrolidine-2-one compound fused with aromatic heterocycle
Seuls les utilisateurs enregistrés peuvent traduire des articles
Se connecter S'inscrire
BACKGROUND ART
Arginine-vasopressin (AVP) is a peptide consisting of 9 amino acids which is synthesized predominantly in the hypothalamus, and is deeply involved as a posterior pituitary hormone in the regulation of blood plasma osmotic pressure, blood pressure and amount of body fluid.
To date,
Plasminogen activator as an anti-inflammatory agent
Seuls les utilisateurs enregistrés peuvent traduire des articles
Se connecter S'inscrire
BACKGROUND OF THE INVENTION
1. Field of the Invention
The present invention relates to the use of plasminogen activator as an anti-inflammatory agent.
2. Description of the Related Art
Plasminogen activators play an important physiological role in the regulation of thrombolysis. This action is
Azole derivative
Seuls les utilisateurs enregistrés peuvent traduire des articles
Se connecter S'inscrire
CROSS REFERENCE TO RELATED APPLICATIONS
This application is a National Stage of International Application No. PCT/JP2012/077541 filed Oct. 25, 2012, claiming priority based on Japanese Patent Application No. 2011-236487, filed Oct. 27, 2011.
TECHNICAL FIELD
The present invention relates to a
Method of noninvasive treatment of diabetic retinopathy
Seuls les utilisateurs enregistrés peuvent traduire des articles
Se connecter S'inscrire
FIELD OF THE INVENTION
The present invention relates generally to a method for noninvasive treatment of diabetic retinopathy. More so, the present invention relates to a method that prevents and reverses diabetic retinopathy and other vascular retinopathies using a series of non-invasive light and
La base de données d'herbes médicinales la plus complète soutenue par la science
- Fonctionne en 55 langues
- Cures à base de plantes soutenues par la science
- Reconnaissance des herbes par image
- Carte GPS interactive - étiquetez les herbes sur place (à venir)
- Lisez les publications scientifiques liées à votre recherche
- Rechercher les herbes médicinales par leurs effets
- Organisez vos intérêts et restez à jour avec les nouvelles recherches, essais cliniques et brevets
Tapez un symptôme ou une maladie et lisez des informations sur les herbes qui pourraient aider, tapez une herbe et voyez les maladies et symptômes contre lesquels elle est utilisée.
* Toutes les informations sont basées sur des recherches scientifiques publiées
